Alder Biopharmaceuticals, Inc.
(NASDAQ : ALDR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.90%58.570.0%$906.01m
AMGNAmgen, Inc. 1.22%258.241.3%$750.82m
GILDGilead Sciences, Inc. 0.38%76.351.0%$724.94m
REGNRegeneron Pharmaceuticals, Inc. 2.18%622.452.5%$659.43m
NVAXNovavax, Inc. 2.43%81.64102.0%$580.82m
BIIBBiogen, Inc. 0.13%265.121.6%$559.05m
VRTXVertex Pharmaceuticals, Inc. 1.68%291.101.9%$527.74m
ILMNIllumina, Inc. 1.24%373.103.5%$308.62m
ALXNAlexion Pharmaceuticals, Inc. -0.08%112.302.0%$228.46m
BMRNBioMarin Pharmaceutical, Inc. 0.75%126.784.3%$214.78m
SGENSeattle Genetics, Inc. 0.90%169.036.1%$202.30m
SRNESorrento Therapeutics, Inc. -1.15%6.851.8%$184.40m
SRPTSarepta Therapeutics, Inc. -1.77%162.7513.9%$167.23m
INCYIncyte Corp. 3.72%106.472.5%$163.35m
IMMUImmunomedics, Inc. 1.71%37.5411.0%$159.56m

Company Profile

Alder's mission is to help alleviate human suffering by generating better and safer antibody therapeutics through novel technologies. Alder plays two roles: As a biopharmaceutical company, Alder uses its proprietary technologies to uniquely identify, develop, produce and market its own antibody therapeutics. The work being done at Alder today will help those who suffer from cancer, autoimmune diseases, and inflammatory diseases. As a licensing partner, Alder is revolutionizing the way the pharmaceutical industry discovers, develops and produces antibody therapeutics. Through various licensing agreements, Alder has used its proprietary technology to help major biopharmaceutical partners advance novel therapeutics to the clinic in less time and at lower cost. Alder's licensing strategy also includes identifying strategic partners to assist in the development and marketing of its preclinical and clinical pipeline programs.